Myd88 Homodimerization Inhibitors
    5.
    发明申请
    Myd88 Homodimerization Inhibitors 审中-公开
    Myd88同型二聚体抑制剂

    公开(公告)号:US20080064643A1

    公开(公告)日:2008-03-13

    申请号:US11793516

    申请日:2005-12-16

    IPC分类号: A61K38/04 A61P43/00 C07K7/02

    摘要: The present invention relates to peptidic and peptidomimetic compounds with the formula (X−)AA1-AA2-AA3-AA4-AA5-AA6-AA7 in which the various groups are defined in the description here below, which mimic a particular protein portion of MyD88, preventing its homodimerisation and interfering with its interaction with the TIR domain. The present invention also provides procedures for the preparation of said compounds, pharmaceutical compositions containing them and their use as medicaments, particularly for the treatment of inflammatory and autoimmune diseases.

    摘要翻译: 本发明涉及具有式<βin-line-formula description =“In-line Formulas”end =“lead”→(X - >)的肽和拟肽化合物 5A-A 2 A 2 A 3 A 3 A 3 A 3 A 3 A 3 A A 3 A 3 其中在下面的描述中定义了各种组,其中哪个是在线公式描述=“在线公式”end =“tail”?> 模拟MyD88的特定蛋白质部分,防止其同二聚化并干扰其与TIR结构域的相互作用。 本发明还提供制备所述化合物的方法,含有它们的药物组合物及其作为药物的用途,特别是用于治疗炎性和自身免疫性疾病。